Sanofi_Aventis_Genzyme.sff.jpg - Washington Times
Skip to content

FILE - In this Feb. 11, 2009 file photo, Chris Viehbacher CEO of Sanofi-Aventis SA, gestures while announcing the 2008 full year result in Paris. French drug maker Sanofi-Aventis SA has agreed to buy Genzyme Corp. in a sweetened all-cash deal that values the U.S. biotechnology company at $20.1 billion Wednesday, Feb. 16, 2011, ending months of corporate haggling. (AP Photo/Michel Euler, file)
Photo by: Michel Euler
FILE - In this Feb. 11, 2009 file photo, Chris Viehbacher CEO of Sanofi-Aventis SA, gestures while announcing the 2008 full year result in Paris. French drug maker Sanofi-Aventis SA has agreed to buy Genzyme Corp. in a sweetened all-cash deal that values the U.S. biotechnology company at $20.1 billion Wednesday, Feb. 16, 2011, ending months of corporate haggling. (AP Photo/Michel Euler, file)

Featured Photo Galleries

Mahan 3.jpg

Say hello, Assad: See the Navy warships off the coast of Syria

The Navy has sent four warships — USS Ramage, USS Mahan, USS Gravely and USS Barry — armed with ballistic missiles into the eastern Mediterranean Sea amid violence in Syria. Navy ships are capable of a variety of military actions, including launching Tomahawk cruise missiles as they did against Libya in 2011.